Synthesis and 5-HT1A, 5-HT2A receptor activity of new β-tetralonohydantoins

European Journal of Medicinal Chemistry

Volumn 40, Issue 8, 2005, Pages 820-829

  Byrtus, Hanna ^a   Pawłowski, Maciej ^a   Czopek, Anna ^a   Bojarski, Andrzej J ^b   Duszyńska, Beata ^b   Nowak, Gabriel ^a   Kłodzińska, Aleksandra ^c   Tatarczyńska, Ewa ^c   Wesołowska, Anna ^c   Chojnacka Wójcik, Ewa ^c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

^c INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

tetralonohydantoins; 1 arylpiperazine derivatives; 5 HT 1A 5 HT2A functional activity; 5HT1A; 5HT2A, D1 D2 receptor affinity; Anxiolytics antidepressants

Indexed keywords

HYDANTOIN DERIVATIVE;

ARTICLE; BINDING AFFINITY; DRUG EFFECT; DRUG SYNTHESIS; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; DRUG EVALUATION, PRECLINICAL; HYDANTOINS; MICE; RATS; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 23944503869     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2004.07.013     Document Type: Article

References (35)

1. D. Hoyer, D.E. Clarke, J.R. Fozard, G.R. Martin, E.J. Mylecharane, P.R. Saxena, and P.P. Humprey Pharmacol. Rev. 46 1994 157
2. J.C. Pecknold CNS Drugs 2 1994 234 251
3. L.E. Schlechter, P. Mc Gonile, and J. Boerrett Curr. Opin. CPNS Invest. Drugs 1 1999 432 446
4. S. Miyamoto, G.E. Duncan, R.B. Mailman, and J.A. Lieberman Curr. Opin. CPNS Invest. Drugs 2 2000 25 39
5. R.A. Glennon, and M. Dukat Curr. Drugs: Serotonin 1 1992 1 45
6. H. Byrtus, M. Pawłowski, S. Charakchieva-Minol, B. Duszyńska, M.J. Mokrosz, and J.L. Mokrosz Arch. Pharm. Pharm. Med. Chem. 329 1996 283 290
7. I. Wolska, H. Byrtus, and A. Zejc Pol. J. Chem. 71 1997 1005 1011
8. H. Byrtus, M. Pawłowski, B. Duszyńska, A. Wesołowska, E. Chojnacka-Wójcik, and A.J. Bojarski Pol. J. Pharmacol. 53 2001 395 401
9. M.L. Lopez-Rodriguez, M.L. Rosado, B. Benhamu, M.J. Morcillo, E. Fernandez, and K.J. Schaper J. Med. Chem. 40 1997 1648 1656
10. M.L. Lopez-Rodriguez, M.J. Morcillo, E. Fernandez, E. Porras, L. Orensanz, M.E. Beneytez, J. Manzanares, and J.A. Fuentes J. Med. Chem. 44 2001 186 197
11. M.L. Lopez-Rodriguez, M.J. Morcillo, E. Fernandez, M.L. Rosado, L. Pardo, and K.J. Schaper J. Med. Chem. 44 2001 198 207
12. M.L. Lopez-Rodriguez, M.L. Rosado, B. Benhamu, M.J. Morcillo, A.M. Sanz, L. Orensanz, M.E. Beneytez, J.A. Fuentes, and J. Manzanares J. Med. Chem. 39 1996 4439 4450
13. M.L. Lopez-Rodriguez, D. Ayala, A. Viso, B. Benhamú, R.F. De la Pradilla, F. Zarza, and J.A. Ramos Bioorg. Med. Chem. 12 2004 1551 1557
14. M.L. Lopez-Rodriguez, D. Ayala, B. Benhamu, M.J. Morcillo, and A. Viso Curr. Med. Chem. 9 2002 443 469
15. L.H. Goodson, J.L. Honigberg, J.L. Lehman, and W.H. Burton J. Org. Chem. 25 1960 1920 1924
16. H.H.G. Berendsen, and F. Jenck C.L.E Broekkamp Pharmacol. Biochem. Behav. 33 1989 821 827
17. M.D. Tricklebank, C. Forler, and J.R. Fozard Eur. J. Pharmacol. 106 1984 271 282
18. E.A. Forster, I.A. Cliffe, D.J. Bill, G.M. Dover, J. Jones, Y. Reilly, and A.A. Fletcher Eur. J. Pharmacol. 281 1995 81 88
19. J.L. Mokrosz, M.H. Paluchowska, E. Chojnacka-Wójcik, M. Filip, S. Charakchieva-Minol, and A. Dereń-Wesołek J. Med. Chem. 37 1994 2754 2760
20. E. Przegaliński, M. Filip, B. Budziszewska, and E. Chojnacka-Wójcik Pol. J. Pharmacol. 46 1994 21 27
21. G.M. Goodwin, R.J. De Souza, and A.R. Green Neuropharmacology 24 1985 1187 1194
22. K.F. Martin, and D.J. Heal J.R. Fozard P.R. Saxena Serotonin: Molecular Biology, Receptors and Functional Effects 1991 Birkhauser Verlag, Basel 483 490
23. N.A. Darmani, B.R. Martin, V. Pandey, and R.A. Glennon Pharmacol. Biochem. Behav. 36 1990 901 906
24. J. De Vry Psychopharmacol. (Berl.) 121 1995 1 26
25. M. Bourin, and M. Hascoët Curr. Opin. Invest. Drugs 2 2001 259 265
26. Drug Status Update Serotonin 3 1998 164 173
27. E. Chojnacka-Wójcik, A. Kłodzińska, E. Tatarczyńska, and M.H. Paluchowska Pol. J. Pharmacol. 51 1999 405 413
28. G. Griebel, R.J. Rodgers, G. Perrault, and D.J. Sanger Psychopharmacol. (Berl.) 144 1999 121 130
29. G. Griebel, R.J. Rodgers, G. Perrault, and D.J. Sanger Neuropharmacology 39 2000 1848 1857
30. R.J. Rodgers, and J.C. Cole Eur. J. Pharmacol. 261 1994 321 325
31. A.J. Bojarski, M.T. Cegła, S. Charakchieva-Minol, M.J. Mokrosz, M. Maćkowiak, and J.L. Mokrosz Pharmazie 48 1993 289 294
32. G. Ossowska, G. Nowak, R. Kata, B. Klenk-Majewska, Z. Danilczuk, and I. Zebrowska-Łupina J Neural Transm. 108 2001 311 319
33. S. Pellow, and S. File Pharmacol. Biochem. Behav. 24 1986 525 529
34. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Eur. J. Pharmacol. 47 1978 379 391
35. P.A. Janssen, A.H. Jageneau, and K.H. Schellekens Psychopharmacologia 1 1960 389 392